Index | CSI 300 Health Care |
Investment focus | Equity, China, Health Care |
Fund size | GBP 4 m |
Total expense ratio | 0.50% p.a. |
Replication | Synthetic (Funded swap) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | No |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in GBP) | 0.00% |
Inception/ Listing Date | 7 January 2013 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Luxembourg |
Fund Provider | Xtrackers |
Fund Structure | Company With Variable Capital (SICAV) |
UCITS compliance | Yes |
Administrator | State Street Bank Luxembourg S.C.A. |
Investment Advisor | State Street Global Advisors Limited |
Custodian Bank | State Street Bank Luxembourg S.C.A. |
Revision Company | Ernst & Young S.A. |
Fiscal Year End | 31 December |
Swiss representative | Deutsche Bank (Suisse) SA |
Swiss paying agent | Deutsche Bank (Suisse) SA |
Germany | Tax transparent |
Switzerland | ESTV Reporting |
Austria | Tax Reporting Fund |
UK | UK Reporting |
Indextype | - |
Swap counterparty | Deutsche Bank AG |
Collateral manager | The Bank of New York Mellon (Luxembourg) S.A. |
Securities lending | No |
Securities lending counterparty |
YTD | +0.00% |
1 month | +0.00% |
3 months | +0.00% |
6 months | +0.00% |
1 year | +0.00% |
3 years | +9.20% |
5 years | +72.19% |
Since inception (MAX) | - |
2023 | +0.00% |
2022 | +7.48% |
2021 | +7.34% |
2020 | +34.40% |
Volatility 1 year | 0.00% |
Volatility 3 years | 8.39% |
Volatility 5 years | 23.65% |
Return per risk 1 year | - |
Return per risk 3 years | 0.35 |
Return per risk 5 years | 0.49 |
Maximum drawdown 1 year | - |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | - |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
KraneShares MSCI All China Health Care Index UCITS ETF USD | 2 | 0.65% p.a. | Accumulating | Full replication |
Global X China Biotech UCITS ETF USD Accumulating | 0 | 0.68% p.a. | Accumulating | Full replication |